Exchange Rates 2008

Return to Exchange Rates

Table Of Contents

1. December 2008
2. November 2008
3. October 2008
4. September 2008
5. August 2008
6. July 2008
7. June 2008
8. May 2008
9. April 2008
10. March 2008
11. February 2008
12. January 2008

December 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2008 will be used in the review of prices for existing medicines in the second half of 2008.

The international prices of an existing drug product for the period January to December 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2008

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

November 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2008 will be used in the review of prices for existing medicines in the first half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

October 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each
country for the 36-month period ending June 2008 will be used in the review of
prices for existing medicines in the first half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

September 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each
country for the 36-month period ending June 2008 will be used in the review of
prices for existing medicines in the first half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2008

New Drug Products

The simple average of the monthly average noon spot exchange rates for each
country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

August 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2008 will be used in the review of prices for existing medicines in the first half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

July 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2008 will be used in the review of prices for existing medicines in the second half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

For more information call our toll-free number 1 877 861-2350

June 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2008 will be used in the review of prices for existing medicines in the second half of 2008.

The international prices of an existing drug product for the period January to June 2008 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

For more information call our toll-free number 1 877 861-2350

May 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced November 2007 to October 2008

April 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced October 2007 to September 2008

March 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced September 2007 to August 2008

February 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2007 to July 2008

January 2008

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.